BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20129318)

  • 1. Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression.
    Fehlbaum-Beurdeley P; Jarrige-Le Prado AC; Pallares D; Carrière J; Guihal C; Soucaille C; Rouet F; Drouin D; Sol O; Jordan H; Wu D; Lei L; Einstein R; Schweighoffer F; Bracco L
    Alzheimers Dement; 2010 Jan; 6(1):25-38. PubMed ID: 20129318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene expression pattern in blood for the early detection of Alzheimer's disease.
    Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.
    Calciano MA; Zhou W; Snyder PJ; Einstein R
    Alzheimers Dement; 2010 Sep; 6(5):386-93. PubMed ID: 20185375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.
    Fehlbaum-Beurdeley P; Sol O; Désiré L; Touchon J; Dantoine T; Vercelletto M; Gabelle A; Jarrige AC; Haddad R; Lemarié JC; Zhou W; Hampel H; Einstein R; Vellas B;
    J Alzheimers Dis; 2012; 32(1):169-81. PubMed ID: 22785402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.
    Mocali A; Cedrola S; Della Malva N; Bontempelli M; Mitidieri VA; Bavazzano A; Comolli R; Paoletti F; La Porta CA
    Exp Gerontol; 2004 Oct; 39(10):1555-61. PubMed ID: 15501026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
    J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Developing a blood test for Alzheimer's disease using advanced genomic expression technology.
    Einstein R
    Alzheimers Dement; 2010 Mar; 6(2):147-9. PubMed ID: 20298978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.
    Cacabelos R; Fernández-Novoa L; Corzo L; Pichel V; Lombardi V; Kubota Y
    Methods Find Exp Clin Pharmacol; 2004; 26(6):421-44. PubMed ID: 15349138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared spectroscopy of blood plasma for diagnosis of sporadic Alzheimer's disease.
    Burns DH; Rosendahl S; Bandilla D; Maes OC; Chertkow HM; Schipper HM
    J Alzheimers Dis; 2009; 17(2):391-7. PubMed ID: 19363272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
    Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.
    Di Rosa M; Dell'Ombra N; Zambito AM; Malaguarnera M; Nicoletti F; Malaguarnera L
    Eur J Neurosci; 2006 May; 23(10):2648-56. PubMed ID: 16817867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
    Lee HG; Ueda M; Zhu X; Perry G; Smith MA
    J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
    Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
    Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying blood biomarkers for mood disorders using convergent functional genomics.
    Le-Niculescu H; Kurian SM; Yehyawi N; Dike C; Patel SD; Edenberg HJ; Tsuang MT; Salomon DR; Nurnberger JI; Niculescu AB
    Mol Psychiatry; 2009 Feb; 14(2):156-74. PubMed ID: 18301394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel blood test for the early detection of Alzheimer's disease.
    Rye PD; Booij BB; Grave G; Lindahl T; Kristiansen L; Andersen HM; Horndalsveen PO; Nygaard HA; Naik M; Hoprekstad D; Wetterberg P; Nilsson C; Aarsland D; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):121-9. PubMed ID: 20930265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.
    Grünblatt E; Bartl J; Zehetmayer S; Ringel TM; Bauer P; Riederer P; Jacob CP
    J Alzheimers Dis; 2009; 16(3):627-34. PubMed ID: 19276557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy.
    Balistreri CR; Grimaldi MP; Vasto S; Listi F; Chiappelli M; Licastro F; Lio D; Caruso C; Candore G
    Ann N Y Acad Sci; 2006 Nov; 1089():454-61. PubMed ID: 17261788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease.
    Chen KD; Chang PT; Ping YH; Lee HC; Yeh CW; Wang PN
    Neurobiol Dis; 2011 Sep; 43(3):698-705. PubMed ID: 21669286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.